The Oncology Institute Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for The Oncology Institute, Inc. (TOI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-53.01-83.070.15-10.93-14.32
Depreciation & Amortization6.295.875.843.393.18
Deferred Income Tax0.00-0.08-0.26-1.240.00
Stock Based Compensation11.1517.8127.6824.540.15
Change in Working Capital18.062.36-22.14-14.490.99
Change in Accounts Receivable-5.77-4.56-20.29-2.20-6.76
Change in Inventory3.64-4.39-1.73-1.84-0.47
Change in Accounts Payable9.224.80-6.062.923.76
Change in Other Working Capital6.315.40-56.77-12.363.81
Other Operating Activities6.315.4038.2420.43-1.34
Net Cash from Operating Activities-26.54-36.32-61.76-32.680.51
Investing Activities
Capital Expenditures-3.79-4.575.533.05-1.19
Acquisitions0.00-4.46-67.79-34.00-0.15
Purchases of Investments0.00-9.60-117.510.000.00
Sales/Maturities of Investments50.0081.26-117.51-0.200.00
Other Investing Activities0.000.000.000.00-7.50
Net Cash from Investing Activities46.2162.64-131.61-12.15-8.84
Financing Activities
Debt Repayment-0.04-0.10-3.72-7.250.00
Common Stock Issued0.080.13-9.000.000.05
Common Stock Repurchased0.00-1.02-9.000.000.00
Other Financing Activities-3.53-5.85-5.93141.26-0.34
Net Cash from Financing Activities-3.49-6.8592.21154.0111.89
Summary
Net Change in Cash16.1819.48-101.16109.183.55
Cash at Beginning of Period33.4914.01115.176.000.00
Cash at End of Period49.6733.4914.01115.170.00
Free Cash Flow-30.33-40.88-67.29-35.73-0.69
Supplemental Disclosures
Interest Paid4.504.510.220.280.23
Income Taxes Paid0.000.400.151.730.21